NO20020084D0 - Preparater med vedvarende frigivelse, fremgangsmåter for fremstille disse og anvendelser av disse - Google Patents

Preparater med vedvarende frigivelse, fremgangsmåter for fremstille disse og anvendelser av disse

Info

Publication number
NO20020084D0
NO20020084D0 NO20020084A NO20020084A NO20020084D0 NO 20020084 D0 NO20020084 D0 NO 20020084D0 NO 20020084 A NO20020084 A NO 20020084A NO 20020084 A NO20020084 A NO 20020084A NO 20020084 D0 NO20020084 D0 NO 20020084D0
Authority
NO
Norway
Prior art keywords
salt
sustained
preparing
applications
methods
Prior art date
Application number
NO20020084A
Other languages
English (en)
Other versions
NO20020084L (no
Inventor
Yasutaka Igari
Yoshio Hata
Kazumichi Yamamoto
Original Assignee
Takeda Chemical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Takeda Chemical Industries Ltd filed Critical Takeda Chemical Industries Ltd
Publication of NO20020084D0 publication Critical patent/NO20020084D0/no
Publication of NO20020084L publication Critical patent/NO20020084L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1641—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poloxamers
    • A61K9/1647—Polyesters, e.g. poly(lactide-co-glycolide)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/08—Drugs for disorders of the urinary system of the prostate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Biophysics (AREA)
  • Endocrinology (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • Reproductive Health (AREA)
  • Diabetes (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Biological Depolymerization Polymers (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Polyesters Or Polycarbonates (AREA)
NO20020084A 1999-07-15 2002-01-08 Vedvarende frigivelsessammensetninger, fremgangsmåter for fremstilling av disse, og anvendelse av disse NO20020084L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP20188799 1999-07-15
PCT/JP2000/004683 WO2001005380A1 (fr) 1999-07-15 2000-07-13 Compositions a liberation lente, techniques de production et methodes d'utilisation

Publications (2)

Publication Number Publication Date
NO20020084D0 true NO20020084D0 (no) 2002-01-08
NO20020084L NO20020084L (no) 2002-03-14

Family

ID=16448493

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20020084A NO20020084L (no) 1999-07-15 2002-01-08 Vedvarende frigivelsessammensetninger, fremgangsmåter for fremstilling av disse, og anvendelse av disse

Country Status (21)

Country Link
US (2) US7265157B1 (no)
EP (1) EP1197208B1 (no)
KR (1) KR20020012312A (no)
CN (1) CN1361685A (no)
AT (1) ATE360413T1 (no)
AU (1) AU5853000A (no)
BR (1) BR0012400A (no)
CA (1) CA2378714A1 (no)
CZ (1) CZ2002114A3 (no)
DE (1) DE60034568T2 (no)
HK (1) HK1042237A1 (no)
HU (1) HUP0202880A3 (no)
IL (1) IL147417A0 (no)
MX (1) MXPA02000461A (no)
NO (1) NO20020084L (no)
NZ (1) NZ516466A (no)
PL (1) PL352499A1 (no)
RU (1) RU2002103718A (no)
SK (1) SK342002A3 (no)
WO (1) WO2001005380A1 (no)
ZA (1) ZA200200347B (no)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1048301A4 (en) * 1998-01-16 2005-03-09 Takeda Chemical Industries Ltd COMPOSITIONS WITH DELAYED ACTIVE INGREDIENTS, PROCESS FOR THEIR PREPARATION AND THEIR USE
PT1158014E (pt) 1998-12-15 2005-04-29 Takeda Pharmaceutical Processo para a producao de poliesteres biodegradaveis
WO2002012369A1 (fr) 2000-08-07 2002-02-14 Wako Pure Chemical Industries, Ltd. Polymere d'acide lactique et son procede de preparation
EP1374855A1 (en) * 2001-03-30 2004-01-02 Takeda Chemical Industries, Ltd. Medicinal solutions
US20040235748A1 (en) * 2001-04-25 2004-11-25 Yasutaka Igari Agents for preventing postoperative recurrence of premenopausal breast cancer
US6693134B2 (en) 2001-05-29 2004-02-17 Chemokine Therapeutics Corporation Bicyclic aromatic chemokine receptor ligands
AR034641A1 (es) * 2001-06-29 2004-03-03 Takeda Pharmaceutical Composicion de liberacion controlada y metodo para producirla
WO2003055470A1 (fr) * 2001-12-26 2003-07-10 Takeda Chemical Industries, Ltd. Nouvelle microsphere et son procede de production
CA2490351C (en) 2002-06-25 2011-11-01 Takeda Pharmaceutical Company Limited Process for producing sustained-release composition
BRPI0412211A (pt) * 2003-07-23 2006-08-22 Pr Pharmaceuticals Inc composições de liberação controlada
US7906125B2 (en) 2003-09-18 2011-03-15 Boston Scientific Scimed, Inc. Solid or semi-solid therapeutic formulations
US20050064045A1 (en) * 2003-09-18 2005-03-24 Sheng-Ping Zhong Injectable therapeutic formulations
TW200529890A (en) 2004-02-10 2005-09-16 Takeda Pharmaceutical Sustained-release preparations
EP1679065A1 (en) * 2005-01-07 2006-07-12 OctoPlus Sciences B.V. Controlled release compositions for interferon based on PEGT/PBT block copolymers
US8263109B2 (en) 2005-05-09 2012-09-11 Boston Scientific Scimed, Inc. Injectable bulking compositions
US7862552B2 (en) 2005-05-09 2011-01-04 Boston Scientific Scimed, Inc. Medical devices for treating urological and uterine conditions
WO2007070563A2 (en) * 2005-12-13 2007-06-21 Harkness Pharmaceuticals, Inc. Stable solid forms of enterostatin
JP2009523122A (ja) * 2005-12-13 2009-06-18 ハルクネスス プハルマセウティカルス，インコーポレイテッド エンテロスタチンを使用して肥満を治療する方法
JP2009542813A (ja) * 2006-07-11 2009-12-03 ハルクネスス プハルマセウティカルス，インコーポレイテッド 飽食因子を使用して肥満を治療する方法
US7858663B1 (en) * 2007-10-31 2010-12-28 Pisgah Laboratories, Inc. Physical and chemical properties of thyroid hormone organic acid addition salts
NZ577281A (en) 2006-12-18 2011-12-22 Takeda Pharmaceutical Sustained-release composition and method for producing the same

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1996022786A1 (en) * 1995-01-23 1996-08-01 Takeda Chemical Industries, Ltd. Sustained-release preparation and use
ES2221019T3 (es) 1996-10-31 2004-12-16 Takeda Chemical Industries, Ltd. Preparacion de liberacion mantenida.
AU5678398A (en) 1997-01-29 1998-08-18 Takeda Chemical Industries Ltd. Sustained-release microspheres, their production and use
EP1048301A4 (en) * 1998-01-16 2005-03-09 Takeda Chemical Industries Ltd COMPOSITIONS WITH DELAYED ACTIVE INGREDIENTS, PROCESS FOR THEIR PREPARATION AND THEIR USE
JPH11269094A (ja) * 1998-01-16 1999-10-05 Takeda Chem Ind Ltd 徐放性組成物、その製造法および用途
PT1158014E (pt) 1998-12-15 2005-04-29 Takeda Pharmaceutical Processo para a producao de poliesteres biodegradaveis

Also Published As

Publication number Publication date
NO20020084L (no) 2002-03-14
ZA200200347B (en) 2003-03-26
BR0012400A (pt) 2002-05-21
CA2378714A1 (en) 2001-01-25
US7265157B1 (en) 2007-09-04
RU2002103718A (ru) 2003-10-10
SK342002A3 (en) 2002-05-09
DE60034568D1 (de) 2007-06-06
HUP0202880A2 (hu) 2003-01-28
EP1197208A4 (en) 2004-06-30
ATE360413T1 (de) 2007-05-15
EP1197208B1 (en) 2007-04-25
US20080014237A1 (en) 2008-01-17
MXPA02000461A (es) 2002-07-30
NZ516466A (en) 2003-02-28
HUP0202880A3 (en) 2003-04-28
PL352499A1 (en) 2003-08-25
EP1197208A1 (en) 2002-04-17
AU5853000A (en) 2001-02-05
CN1361685A (zh) 2002-07-31
WO2001005380A1 (fr) 2001-01-25
KR20020012312A (ko) 2002-02-15
DE60034568T2 (de) 2008-01-03
IL147417A0 (en) 2002-08-14
HK1042237A1 (zh) 2002-08-09
CZ2002114A3 (cs) 2002-04-17

Similar Documents

Publication Publication Date Title
NO20020084D0 (no) Preparater med vedvarende frigivelse, fremgangsmåter for fremstille disse og anvendelser av disse
CY1117889T1 (el) Πολυμερες γαλακτικου οξεος και διεργασια για την παραγωγη αυτου
HUP0100221A2 (hu) Nyújtott hatású készítmény és eljárás az előállítására, valamint alkalmazása
GEP20053470B (en) N-Heteroaryl-Pyridinesulfonamide Derivatives and Their Use as Endothelin Antagonists
DK0839525T3 (da) Præparat med forlænget frigivelse
HUP0400382A2 (hu) Késleltetett leadású készítmény és eljárás annak előállítására
TNSN90032A1 (fr) Derives de n-(3-hydroxy-4-piperidinyl) (dihydro-benzofuranne, dihydro-2h-benzopyranne ou dihydro-benzodioxin) carboxamide, et leur procede de preparation
MX9803004A (es) Nuevos derivados de aminoacidos, procedimiento para su preparacion y composiciones farmaceuticas que contienen estos compuestos.
HUT60507A (en) Process for producing trifluoromethyl ketone derivatives and pharmaceutical compositions comprising same as active ingredient
FI884375A0 (fi) Menetelmä terapeuttisesti käyttökelpoisten N-(1-alkyyli-3-hydroksi-4-piperidinyyli)bentsamidien valmistamiseksi
SE9600716L (sv) Adhesionsinhibitorer, preparat innehållande desamma och förfarande för framställning därav
MY142066A (en) Controlled release composition comprising lactic acid polymer, and method of producing the same
NO178660C (no) Analogifremgangsmåte for fremstilling av N-aryl-piperazinalkanamidforbindelser
EP0790252A4 (en) FUMARIC ACID DERIVATIVE AND POLYMER THEREOF
EP2239270A3 (en) Low molecular weight peptide derivatives as inhibitors of the Laminin/Nidogen interaction
GR1000429B (el) Συνθεση με βαση την τριμεβουτινη παρατεταμενης απελευθερωσης και μεθοδος παρασκευης της.
JP2001510860A5 (no)
EE9700290A (et) Meetod kinoloonkarboksüülhapete ja naftüridiinkarboksüülhapete saamiseks vabade aluste kujul
JP4699635B2 (ja) 徐放性薬剤組成物
IT1276161B1 (it) Derivati dell'acido fosfonico ad attivita' inibitrice delle metallopeptidasi
DE69908771D1 (de) Tilidin-mesylat, verfahren zu dessen herstellung und pharmazeutische zusammensetzungen
ATE32342T1 (de) N-nitroso-n-(beta-chloro-aethyl)-carboroylpeptide.
TH101402B (th) สารผสมที่ออกฤทธิ์นาน และกรรมวิธีสำหรับผลิตสารเดียวกันนี้
JPS6452774A (en) Amide derivative, production thereof and plant disease controlling agent containing said derivative as active ingredient
TH33723A (no)

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application